Cameron Durrant

Insider Reports History

Location
Califon, NJ
Signature
/s/ Henry Madrid, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cameron Durrant:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HUMANIGEN, INC Chief Executive Officer, Director Stock Option (Right to Buy) 809K $3.66M $4.53 27 Jul 2022 Direct

Insider Reports Filed by Cameron Durrant

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HGEN HUMANIGEN, INC 27 Jul 2022 1 $0 4 Chief Executive Officer, Director 29 Jul 2022, 18:30
HGEN HUMANIGEN, INC 02 Mar 2022 1 $93.6K 4 Chief Executive Officer, Director 04 Mar 2022, 05:06
HGEN HUMANIGEN, INC 12 Jan 2022 1 $0 4 Chief Executive Officer, Director 14 Jan 2022, 16:06
HGEN HUMANIGEN, INC 31 Dec 2021 1 $0 4 Chief Executive Officer, Director 04 Jan 2022, 17:20
HGEN HUMANIGEN, INC 23 Nov 2021 1 -$80K 4 Chief Executive Officer, Director 26 Nov 2021, 16:15
HGEN HUMANIGEN, INC 30 Sep 2021 1 $0 4 Chief Executive Officer, Director 04 Oct 2021, 20:07
HGEN HUMANIGEN, INC 14 Jun 2021 5 -$1.68M 4 Chief Executive Officer, Director 16 Jun 2021, 21:40